Curelator Inc.

Curelator Inc.:

Curelator Inc., with the slogan "The Digital Health Platform to practice personalized, evidence-based medicine," is a Health Care startup founded in 2013 in Cambridge, Massachusetts. The company specializes in developing clinical grade, personalized disease management tools for patients and clinicians. Their flagship platform, N1-Headache™, offers individualized disease management tools for individuals with a history of migraine, allowing them to gain insights into their migraine attack patterns and personalized triggers.

One of Curelator's key strengths is its commitment to research and development, as evidenced by the dozens of papers and abstracts it has published in major headache and migraine journals and medical conferences since its inception. Moreover, the company has successfully enrolled thousands of patients in clinical studies through its N1-Headache™ platform.

Curelator's mission revolves around improving healthcare by measuring patient-reported outcomes and the influencing factors, while providing essential data to support the optimization of therapeutic pathways for each individual.

As of now, there is no publicly disclosed information about Curelator's last investment or the involved investors.